Last reviewed · How we verify

NCT05895773

Oro-nasal Decontamination to Prevent Ventilator-associated Pneumonia

Completed Phase 2, PHASE3 Last updated 27 November 2023
What this trial tests

Phase 2, PHASE3 trial testing Povidone-Iodine in Ventilator Associated Pneumonia in 78 participants. Completed in 24 November 2023.

Timeline
24 June 2023
Primary endpoint
24 November 2023
24 November 2023

Quick facts

Lead sponsorMenoufia University
PhasePhase 2, PHASE3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment78
Start date24 June 2023
Primary completion24 November 2023
Estimated completion24 November 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Menoufia University

Who can join

Adults 18 to 70, any sex, with Ventilator Associated Pneumonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It has been shown that oral hygiene reduces the incidence of ventilator-associated pneumonia (VAP). The nasopharynx is considered to be an important source of contaminated micro aspiration to the lung however, the effect of nasopharyngeal decontamination on VAP has not been yet investigated. The investigators hypothesized that decontamination of oral and nasopharyngeal cavities with combined Povidone Iodine and glycyrrhizin would remarkably reduce the incidence of VAP.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Povidone-Iodine

Trials testing the same drug.

Other recruiting trials for Ventilator Associated Pneumonia

Currently open trials in the same condition.

Other Menoufia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05895773.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing